Cloud-clone
SKU:RPE189Hu02
Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
Couldn't load pickup availability
Prokaryotic expression
Product No.
RPE189Hu02
Organism Species
Homo sapiens (Human).
Source
Prokaryotic expression
Host
E.coli
Endotoxin Level
<1.0EU per 1µg (determined by the LAL method)
Subcellular Location
Secreted, Lysosome, Cytoplasm, Endoplasmic reticulum lumen
Predicted Molecular Mass
34.2kDa
Accurate Molecular Mass
37kDa(Analysis of differences refer to the manual)
Residues & Tags
Trp156~Trp461 with N-terminal His Tag
Buffer Formulation
PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Traits
Freeze-dried powder
Purity
> 95%
Isoelectric Point
5.9
Applications
Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
UOM
10µg 50µg 200µg 1mg 5mg
SEQUENCE
USAGE
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Biological Trace Element Research | Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers pubmed:28409410 |
| BASIC RESEARCH IN CARDIOLOGY | Autocrine effects of PCSK9 on cardiomyocytes Pubmed: 33169229 |
| J Transl Med | Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans 33407555 |
| Metabolism | MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice 33775647 |
| Eur Rev Med Pharmacol Sci | Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders 34533801 |
| Clin Exp Hypertens | Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease Pubmed:35502687 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPE189Hu02 | Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPE189Hu01 | Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAE189Hu02 | Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) | WB; IHC; ICC; IP. |
| PAE189Hu01 | Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) | WB; IHC; ICC; IP. |
| LAE189Hu71 | Biotin-Linked Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) | WB; IHC; ICC. |
| SEE189Hu | ELISA Kit for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LME189Hu | Magnetic Luminex Assay Kit for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
